Creating the Next Wave of Cancer Treatments for Patients | Athena Countouriotis, M.D. Chairperson, Avenzo Therapeutics 00:10:00
Athena Countouriotis, M.D., is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics. She most recently led Turning Point Therapeutics as President and Chief Executive Officer through its IPO in 2019 to its eventual acquisition by Bristol Myers Squibb for $4.1 billion in August 2022. During the time period, she and her team raised more than $1.2 billion across multiple equity financings.
